TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 54 filers reported holding TALARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,693 | +84.2% | 900,649 | 0.0% | 0.11% | +82.0% |
| Q4 2022 | $919 | -100.0% | 900,649 | 0.0% | 0.06% | -63.3% |
| Q3 2022 | $2,369,000 | -55.3% | 900,649 | -23.3% | 0.17% | -58.6% |
| Q2 2022 | $5,298,000 | -54.2% | 1,174,723 | 0.0% | 0.40% | -54.8% |
| Q1 2022 | $11,559,000 | -36.1% | 1,174,723 | -0.7% | 0.89% | -17.5% |
| Q4 2021 | $18,081,000 | +10.6% | 1,182,545 | -2.7% | 1.08% | +61.9% |
| Q3 2021 | $16,349,000 | -5.3% | 1,215,847 | 0.0% | 0.66% | +13.3% |
| Q2 2021 | $17,264,000 | – | 1,215,847 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |